Vanda wins Israeli OK for Fanapt in schizophrenia
This article was originally published in Scrip
Executive Summary
The Israeli Ministry of Health granted its blessing for Vanda Pharmaceuticals to market its atypical antipsychotics Fanapt as a treatment for schizophrenia through the company's marketing partner Megapharm.